Thermo Fisher Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 01, 2022
For the nine months, sales was USD 33,465 million compared to USD 28,509 million a year ago. Net income was USD 5,374 million compared to USD 6,067 million a year ago. Basic earnings per share from continuing operations was USD 13.72 compared to USD 15.41 a year ago. Diluted earnings per share from continuing operations was USD 13.62 compared to USD 15.29 a year ago.